Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis

被引：3

作者：

Zhao, Juan ^{[1
]}

Liao, Bin ^{[1
]}

Gong, Li ^{[1
]}

Yang, Huiyao ^{[1
]}

Li, Sha ^{[1
]}

Li, Yongsheng ^{[1
,2
]}

机构：

[1] Chongqing Univ, Canc Hosp, Clin Trial Ctr, Dept Phase 1, Chongqing, Peoples R China

[2] Chongqing Univ, Canc Hosp, Clin Trial Ctr, Dept Phase 1, 181 Hanyu Rd, Chongqing 400030, Peoples R China

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2023年 / 19卷 / 02期

基金：

中国国家自然科学基金;

关键词：

Therapeutic cancer vaccine; bibliometric analysis; immunotherapy; knowledge map; VOSviewer; Citespace; TUMOR MICROENVIRONMENT; IMMUNOTHERAPY; BLOCKADE;

D O I：

10.1080/21645515.2023.2254262

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The investigation of therapeutic cancer vaccines has been ongoing for the past century. Herein, we used VOSviewer and CiteSpace to perform the first global bibliometric analysis of the literature on therapeutic cancer vaccines from 2013 to 2022 aiming to explore the current status and potential research trends. The findings revealed a consistent upward trend in both publication counts and citations. The United States emerged as the leading contributor with the highest number of published papers. Additionally, the analysis of references and keywords indicated that therapeutic cancer vaccines have long been popular topics, whereas neoantigen vaccines, mRNA vaccines, combination strategies, and vaccine delivery systems are emerging research hotspots. This bibliometric study provides a comprehensive and important overview of the current knowledge and potential developments in therapeutic cancer vaccines from 2013 to 2022, which may serve as a valuable reference for scholars interested in further exploring this promising field.

引用

页数：11

共 56 条

[1] Immunobiology of dendritic cells [J].

Banchereau, J ;

Briere, F ;

Caux, C ;

Davoust, J ;

Lebecque, S ;

Liu, YT ;

Pulendran, B ;

Palucka, K .

ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+

[2] Biomaterial-Based In Situ Cancer Vaccines [J].

Bo, Yang ;

Wang, Hua .

ADVANCED MATERIALS, 2024, 36 (43)

[3] The state of h index research Is the h index the ideal way to measure research performance? [J].

Bornmann, Lutz ;

Daniel, Hans-Dieter .

EMBO REPORTS, 2009, 10 (01) :2-6

[4] A co-citation analysis of purpose: trends and (potential) troubles in the foundation of purpose scholarship [J].

Bronk, Kendall Cotton ;

Reichard, Rebecca J. ;

Qi Li, Jia .

JOURNAL OF POSITIVE PSYCHOLOGY, 2023, 18 (06) :1012-1026

[5] DC-based cancer vaccines [J].

Gilboa, Eli .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) :1195-1203

[6] Translational nanoparticle engineering for cancer vaccines [J].

Grippin, Adam J. ;

Sayour, Elias J. ;

Mitchell, Duane A. .

ONCOIMMUNOLOGY, 2017, 6 (10)

[7] Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens [J].

Gubin, Matthew M. ;

Zhang, Xiuli ;

Schuster, Heiko ;

Caron, Etienne ;

Ward, Jeffrey P. ;

Noguchi, Takuro ;

Ivanova, Yulia ;

Hundal, Jasreet ;

Arthur, Cora D. ;

Krebber, Willem-Jan ;

Mulder, Gwenn E. ;

Toebes, Mireille ;

Vesely, Matthew D. ;

Lam, Samuel S. K. ;

Korman, Alan J. ;

Allison, James P. ;

Freeman, Gordon J. ;

Sharpe, Arlene H. ;

Pearce, Erika L. ;

Schumacher, Ton N. ;

Aebersold, Ruedi ;

Rammensee, Hans-Georg ;

Melief, Cornelis J. M. ;

Mardis, Elaine R. ;

Gillanders, William E. ;

Artyomov, Maxim N. ;

Schreiber, Robert D. .

NATURE, 2014, 515 (7528) :577-+

[8] Actively personalized vaccination trial for newly diagnosed glioblastoma [J].

Hilf, Norbert ;

Kuttruff-Coqui, Sabrina ;

Frenzel, Katrin ;

Bukur, Valesca ;

Stevanovic, Stefan ;

Gouttefangeas, Cecile ;

Platten, Michael ;

Tabatabai, Ghazaleh ;

Dutoit, Valerie ;

van der Burg, Sjoerd H. ;

Straten, Per Thor ;

Martinez-Ricarte, Francisco ;

Ponsati, Berta ;

Okada, Hideho ;

Lassen, Ulrik ;

Admon, Arie ;

Ottensmeier, Christian H. ;

Ulges, Alexander ;

Kreiter, Sebastian ;

von Deimling, Andreas ;

Skardelly, Marco ;

Migliorini, Denis ;

Kroep, Judith R. ;

Idorn, Manja ;

Rodon, Jordi ;

Piro, Jordi ;

Poulsen, Hans S. ;

Shraibman, Bracha ;

McCann, Katy ;

Mendrzyk, Regina ;

Loewer, Martin ;

Stieglbauer, Monika ;

Britten, Cedrik M. ;

Capper, David ;

Welters, Marij J. P. ;

Sahuquillo, Juan ;

Kiesel, Katharina ;

Derhovanessian, Evelyna ;

Rusch, Elisa ;

Bunse, Lukas ;

Song, Colette ;

Heesch, Sandra ;

Wagner, Claudia ;

Kemmer-Bruck, Alexandra ;

Ludwig, Joerg ;

Castle, John C. ;

Schoor, Oliver ;

Tadmor, Arbel D. ;

Green, Edward ;

Fritsche, Jens .

NATURE, 2019, 565 (7738) :240-+

[9] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[10] The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification [J].

Jou, Jessica ;

Harrington, Kevin J. ;

Zocca, Mai-Britt ;

Ehrnrooth, Eva ;

Cohen, Ezra E. W. .

CLINICAL CANCER RESEARCH, 2021, 27 (03) :689-703

← 1 2 3 4 5 6 →